参考文献/References:
[1]YANG Y, SCHUBERT MC, KUNER T, et al. Brain tumor networks in diffuse glioma [J]. Neurotherapeutics, 2022, 19(6): 1832-1843.
[2]WU Y, PENG Z, WANG H, et al. Identifying the hub genes of glioma peritumoral brain edema using bioinformatical methods [J]. Brain Sci, 2022, 12(6): 805.
[3]MALIK N, GERAGHTY B, DASGUPTA A, et al. MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region [J]. J Neurooncol, 2021, 155(2): 181-191.
[4]CHEN KY, JIANG PC. Correlation between peritumoral edema of high-grade glioma and patients' prognoses [J]. Chin J Clin Neurosurg, 2021, 26(5): 352-353, 359. 陈科宇,江普查. 瘤周水肿与人脑高级别胶质瘤预后的相关性[J]. 中国临床神经外科杂志,2021,26(5):352-353,359.
[5]SANCAR A, VAN GELDER RN. Clocks, cancer, and chronochemotherapy [J]. Science, 2021, 371(6524): eabb0738.
[6]RAY I, GOSWAMI S. Circadian rhythm genes in cancer: insight into their functions and regulation involving noncoding RNAs [J]. Chronobiol Int, 2021, 38(9): 1231-1243.
[7]MA TJ, ZHANG ZW, LU YL, et al. CLOCK and BMAL1 stabilize and activate RHOA to promote F-actin formation in cancer cells [J]. Exp Mol Med, 2018, 50(10): 1-15.
[8]ZHENG Y, PAN L, WANG F, et al. Neural function of Bmal1: an overview [J]. Cell Biosci, 2023, 13(1): 1.
[9]WANG F, LI C, HAN F, et al. BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2 [J]. Aging (Albany NY), 2021, 13(22): 24675-24685.
[10]WELLER M, VAN DEN BENT M, PREUSSER M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood [J]. Nat Rev Clin Oncol, 2021, 18(3): 170-186.
[11]GAWLITZA M, FIEDLER E, SCHOB S, et al. Peritumoral brain edema in meningiomas depends on aquaporin-4 expression and not on tumor grade, tumor volume, cell count, or Ki-67 labeling index [J]. Mol Imaging Biol, 2017, 19(2): 298-304.
[12]ZHANG H, MA Y, WANG H, et al. MMP-2 expression and correlation with pathology and MRI of glioma [J]. Oncol Lett, 2019, 17(2): 1826-1832.
[13]TANG W, CHEN Y, WANG X, et al. Expression of CXC-motifchemokine 12 and the receptor C-X-C receptor 4 in glioma and the effect on peritumoral brain edema [J]. Oncol Lett, 2018, 15(2): 2501-2507.
[14]WU J, SU R, QIU D, et al. Analysis of DWI in the classification of glioma pathology and its therapeutic application in clinical surgery: a case-control study [J]. Transl Cancer Res, 2022, 11(4): 805-812.
[15]YOU HH, CHEN XY, CHEN JY, et al. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor in vestibular schwannoma [J]. Front Neurol, 2021, 12 (8): 691378.
[16]TAMURA R, OHARA K, SASAKI H, et al. Difference in immunosuppressive cells between peritumoral area and tumor core in glioblastoma [J]. World Neurosurg, 2018, 120(12): e601-e610.
[17]LUO WY, WANG HC, LI XW, et al. Correlation between AQP4, VEGF and peritumoral edema in adult gliomas [J]. J Clin Res, 2022, 39(6): 917-920. 罗文颖,王虎成,李孝伟,等. AQP4、VEGF与成年人脑胶质瘤的瘤周水肿程度的相关性[J]. 医学临床研究,2022,39(6):917-920.
[18]SLAT EA, SPONAGEL J, MARPEGAN L, et al. Cell-intrinsic, Bmal1-dependent circadian regulation of temozolomide sensitivity in glioblastoma [J]. J Biol Rhythms, 2017, 32(2): 121-129.
[19]NAKAZATO R, KAWABE K, YAMADA D, et al. Disruption of Bmal1 impairs blood-brain barrier integrity via pericyte dysfunction [J]. J Neurosci, 2017, 37(42): 10052-10062.